Holen Sie sich die Stockscreener-App
7.85
0.51%
-0.04
Handel nachbörslich:
7.80
-0.05
-0.64%
Schlusskurs vom Vortag:
$7.89
Offen:
$7.92
24-Stunden-Volumen:
119.92K
Relative Volume:
0.51
Marktkapitalisierung:
$2.66B
Einnahmen:
$804.63M
Nettoeinkommen (Verlust:
$-7.13M
KGV:
-372.04
EPS:
-0.0211
Netto-Cashflow:
$-73.42M
1W Leistung:
+4.39%
1M Leistung:
+20.03%
6M Leistung:
-14.77%
1J Leistung:
-53.80%
1-Tages-Spanne:
$7.82
$8.07
1-Wochen-Bereich:
$7.20
$8.09
52-Wochen-Spanne:
$6.28
$20.00
Telix Pharmaceuticals Ltd Adr Stock (TLX) Company Profile
Firmenname
Telix Pharmaceuticals Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare TLX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLX
Telix Pharmaceuticals Ltd Adr
|
7.85 | 2.67B | 804.63M | -7.13M | -73.42M | -0.0211 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Telix Pharmaceuticals Ltd Adr Stock (TLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Citigroup | Buy |
| 2025-08-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-06-05 | Eingeleitet | Wedbush | Outperform |
| 2024-11-15 | Eingeleitet | UBS | Buy |
Telix Pharmaceuticals Ltd Adr Aktie (TLX) Neueste Nachrichten
Stock of the day: Telix Pharmaceuticals - ig.com
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives - GlobeNewswire Inc.
Telix Signals Upcoming Escrow Share Release - Colitco
How new prostate scans could change care: Telix hosts doctor Q&A - Stock Titan
Global prostate scan registry taps AI to predict survival - Stock Titan
Wall Street Bullish on Telix Pharmaceuticals (TLX), Here's Why - Finviz
Telix leaders to speak at Oppenheimer and TD Cowen, sessions streamed live - Stock Titan
Has Adlai Nortye Ltd. Sponsored ADR (ANL) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Telix submits European marketing application for brain cancer imaging agent By Investing.com - Investing.com India
Telix Pharmaceuticals stock rises after European regulatory submission By Investing.com - Investing.com India
Sea Limited Sponsored ADR (SE) Rises Higher Than Market: Key Facts - Yahoo Finance
New Telix brain scan aims to distinguish tumor growth from treatment effects - Stock Titan
Are Investors Undervaluing Yankuang Energy Group Company Limited Sponsored ADR (YZCAY) Right Now? - Yahoo Finance
Here's Why PDD Holdings Inc. Sponsored ADR (PDD) Fell More Than Broader Market - Yahoo Finance
Sea Limited Sponsored ADR (SE) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Is ANZ Group Holdings LimitedSponsored ADR (ANZGY) Outperforming Other Finance Stocks This Year? - Yahoo Finance
Li Auto Inc. Sponsored ADR (LI) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Li Auto Inc. Sponsored ADR (LI) Advances While Market Declines: Some Information for Investors - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Sea Limited Sponsored ADR (SE) Dips More Than Broader Market: What You Should Know - Yahoo Finance
RBC Capital upgrades Telix Pharmaceuticals stock rating to Outperform - Investing.com
Telix begins phase 3 trial to reduce prostate cancer biopsies - Investing.com South Africa
Telix Pharmaceuticals Within The Evolving Precision Oncology Space - Kalkine Media
Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Sahm
Here's What Analysts Think About Telix Pharmaceuticals (TLX) - Finviz
Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact The Gross Law Firm about pending Class ActionTLX - Sahm
Telix Pharmaceuticals Ltd. Sued for Securities Law ViolationsContact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Finviz
Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Barchart.com
Health conference talk to spotlight Telix therapeutic pipeline and products - Stock Titan
Sea Limited Sponsored ADR (SE) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
New Strong Buy Stocks for January 6th - Yahoo Finance
TLX 6-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures - Sahm
FCX IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Freeport-McMoRan Inc. Investors to Secure Counsel Before Important January 12 Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. LawsuitTLX - Sahm
TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - Barchart.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX)January 9, 2026 Deadline to JoinContact Levi & Korsinsky - Sahm
Are Investors Undervaluing ENGIESponsored ADR (ENGIY) Right Now? - Yahoo Finance
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Stockholders to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Is Grupo Cibest S.A.Sponsored ADR (CIB) Stock Outpacing Its Conglomerates Peers This Year? - Yahoo Finance
Prostate scans reshaped treatment for 67% of men in China trial - Stock Titan
[6-K] Telix Pharmaceuticals Ltd Current Report (Foreign Issuer) | TLX SEC FilingForm 6-K - Stock Titan
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately - Finviz
Finanzdaten der Telix Pharmaceuticals Ltd Adr-Aktie (TLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):